Skip to main content

Day: April 11, 2022

OptimumBank Holdings, Inc. (OPHC-NASDAQ) Announces Lending to the Senior Healthcare industry

Fort Lauderdale, FL, April 11, 2022 (GLOBE NEWSWIRE) — OptimumBank (the “Bank”) ended the year 2021 with total loans of $251,399,000 as compared with $154,919,000 from the year 2020 and $104,189,000 from the year ended 2019. The composition of the Bank’s loan portfolio during this period of time included Residential real estate, Multi-family real estate , Commercial real estate, Land and construction, Commercial and Consumer. In addition to starting the year on a positive trend, Chairman Moishe Gubin is also pleased to announce the closing of the Bank’s first healthcare facility loan in January 2022, as was strategically planned in 2021 to address current and future financing needs of the Senior Healthcare Industry. Gubin states “I am especially pleased with the progress that OptimumBank is making in supporting long-term care operators’...

Continue reading

Great Place to Work® Names Jamf as one of the Fortune 100 Best Companies to Work For®

The standard in Apple Enterprise Management now has nearly 2300 employees around the globe, and 96% of its employees say they feel welcomed MINNEAPOLIS, April 11, 2022 (GLOBE NEWSWIRE) — Today, Great Place to Work® and Fortune® magazine announced that Jamf (NASDAQ: JAMF) has been named as one of this year’s 100 Best Companies to Work For. This prestigious award is based entirely on the responses of current employees and what their experiences have been. This is Jamf’s first time being named to this list, coming in at 62nd place. The 2022 Fortune 100 Best Companies to Work For® award is based on an analysis of survey responses from more than 4.5 million current U.S. employees. In that survey, 90% of Jamf’s employees said Jamf is a great place to work. This number is 33% higher than the average U.S. company and makes Jamf one...

Continue reading

Privia Health to Report First Quarter 2022 Results on Thursday, May 12

ARLINGTON, Va., April 11, 2022 (GLOBE NEWSWIRE) — Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2022 before market open on Thursday, May 12, 2022. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company’s Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:30 am ET on the same day, Thursday, May 12th, to discuss the results and management’s outlook for future financial and operational performance. The conference call can be accessed via webcast at ir.priviahealth.com/news-and-events/events-and-presentations or by dialing 855-940-5315 (929-517-0419 for international participants). The webcast will be archived and available...

Continue reading

Amerant Bancorp Inc. to Announce First Quarter 2022 Financial Results and Host Conference Call

CORAL GABLES, Fla., April 11, 2022 (GLOBE NEWSWIRE) — Amerant Bancorp Inc. (NASDAQ: AMTB) (the “Company”), today announced it will release first quarter 2022 earnings results on Wednesday, April 20th, after the market closes. Once released, investors may access Amerant’s earnings results at https://investor.amerantbank.com/ by choosing “Quarterly Results” under the “Financials” heading. On Thursday, April 21, 2022, Jerry Plush, Chief Executive Officer, and Carlos Iafigliola, Chief Financial Officer, will host a conference call at 9:00 AM ET to discuss the Company’s financial and operating results for the quarter. The conference call will be webcast live online and may be accessed through the investor relations section of the Company’s website, www.amerantbank.com. The live conference call may also be accessed by dialing 866-987-6807...

Continue reading

Blue Water Vaccines Inc to Present at World Vaccine Congress Washington 2022

BWV-101 – Universal Influenza Program: Developing a novel vaccine to protect against all influenza strains using groundbreaking mathematical models and researchCINCINNATI, April 11, 2022 (GLOBE NEWSWIRE) — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or “the Company”) a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced that Brian Price, Ph.D., Head of Technology Strategy, will deliver a presentation during the World Vaccine Congress 2022 in Washington, DC. BWV will present on its universal influenza vaccine candidate, which utilizes the exclusively licensed epitopes of limited variability identified by scientists at The University of Oxford. Session details are as follows:Date: Wednesday, April 20, 2022Time: 5:55 p.m. Eastern...

Continue reading

Labrador Uranium Announces Upsize of Bought Deal Private Placement to C$8.0 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, April 11, 2022 (GLOBE NEWSWIRE) — Labrador Uranium Inc. (“LUR” or “Labrador Uranium”) (CSE: LUR) (F: EI1) is pleased to announce that due to significant investment demand, LUR has agreed to amend its agreement with Red Cloud Securities Inc., as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the “Underwriters”), to increase the size of LUR’s previously announced bought deal private placement from C$7.0 million to C$8.0 million. Under the revised offering, the Underwriters have agreed to purchase for resale 5,715,000 flow-through units of LUR to be sold to charitable purchasers (each, a “Charity FT Unit”) at a price of C$1.40 per Charity FT Unit (the “Unit Price”) on a “bought deal”...

Continue reading

DT Midstream Announces Closing of Private Offering of Senior Secured Notes

DETROIT, April 11, 2022 (GLOBE NEWSWIRE) — DT Midstream, Inc. (“DT Midstream” or the “Company”) (NYSE: DTM) today announced that it has closed the previously announced offering (the “Offering”) of $600,000,000 of 4.300% Senior Secured Notes due 2032 (the “Notes”). The Notes were issued by DT Midstream, guaranteed by certain of DT Midstream’s subsidiaries and secured by a first priority lien on certain assets of DT Midstream and its subsidiary guarantors that secure DT Midstream’s existing credit facilities. DT Midstream used the net proceeds from the sale of the Notes to partially repay existing indebtedness under its term loan facility and the transaction is leverage-neutral. The Notes were sold in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities...

Continue reading

Imprivata Acquires SecureLink to Deliver the Only Single-Vendor Platform to Manage and Secure All Enterprise and Third-Party Digital Identities

Imprivata will unlock further value for customers by unifying, integrating, and automating digital identity to enable autonomous identity systems WALTHAM, Mass., April 11, 2022 (GLOBE NEWSWIRE) — Imprivata, the digital identity company for mission- and life-critical industries, today announced it has closed its acquisition of SecureLink, the leader in critical access management with elite patient privacy monitoring. The acquisition uniquely addresses the rapidly growing need for a single source to enable and protect all digital identities, spanning enterprise to third parties. According to CISA, stolen credentials are one of the primary attack vectors for gaining illegal access into networks, including access from supply chains and third-party vendors. In fact, third-party vendors account for 51% of data breaches. Together with...

Continue reading

Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2021 and fiscal year 2021. Fiscal Year 2021 Results Total revenues for fiscal year 2021 were $93.0m compared to $102.0m in 2020, a decrease of 8.8% year on year and were broken down as follows:    Full Year2020 Full Year2021 Increase/(decrease)  US$’000 US$’000 %Point-of-Care 9,215 10,337 12.2%         Clinical Laboratory 92,765 82,628 (10.9%)         Total 101,980 92,965 (8.8%)  Point-of-Care revenues increased from $9.2m in 2020 to $10.3m in 2021, which represents an increase of 12.2%. This was driven by higher HIV sales in Africa. In 2020, HIV revenues...

Continue reading

EXL selected by HealthPartners to develop next-generation care management platform

EXL CareRadius™ delivers integrated population health analytics to identify at-risk patients, spot gaps in care and drive more streamlined care management NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) — EXL [NASDAQ: EXLS], a leading data analytics and digital operations and solutions company, today announced that it was selected by HealthPartners, the largest consumer-governed, non-profit health care organization in the nation, to develop a next-generation care management solution. Leveraging EXL’s CareRadiusTM platform, HealthPartners will now be able to incorporate powerful population health analytics directly into its care management workflow, delivering more targeted, timely and effective interventions and improved member engagement. “In order to deliver truly patient-centric, value-based care it is essential for us to be able...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.